Clinical Trials of Schizophrenia: Optimizing Patient Reported Outcomes and Performance Outcome Assessments Webinar Replay

In schizophrenia trials, clinical outcome assessments (COAs) are traditionally clinician reported outcomes (ClinRO). However, there is growing recognition that patient reported and patient performance data contributes valuable information to such studies. Join Clario (previously ERT) and Cogstate for “Clinical Trials of Schizophrenia: Optimizing Patient Reported Outcomes and Performance Outcome Assessments,” to learn more. Clario’s Jenny Ly, PhD, Senior Clinical Science Advisor, and Cogstate’s Chris Edgar, PhD, Chief Science Officer, will discuss the benefits of using PROs and PerfOs to supplement data collected from ClinROs.